Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.39 |
| ▸ | TRPA1 | O75762 | 2/20 | 0.38 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.38 |
| ▸ | CACNA1C | Q13936 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.36 |
| ▸ | GAA | P10253 | 1/20 | 0.36 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.36 |
| ▸ | HTT | P42858 | 1/20 | 0.36 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.36 |
| ▸ | RNASEH1 | O60930 | 1/20 | 0.34 |
| ▸ | TYR | P14679 | 2/20 | 0.33 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.33 |
| ▸ | GABRB2 | P47870 | 1/20 | 0.33 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.33 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.33 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.33 |
| ▸ | HTR2B | P41595 | 1/20 | 0.33 |
| ▸ | HTR1D | P28221 | 1/20 | 0.33 |
| ▸ | HTR1B | P28222 | 1/20 | 0.33 |
| ▸ | FABP3 | P05413 | 2/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20368242 | 0.86 | TRPA1 (0.31) | LMNATRPA1CHRM1SLC6A2ADRA1A | |
| SCHEMBL12248233 | 0.83 | LMNA (0.39) | LMNATRPA1PTGS1CACNA1CALDH1A1 | |
| SCHEMBL14200344 | 0.82 | LMNA (0.41) | LMNATRPA1PTGS1CACNA1CALDH1A1 | |
| SCHEMBL20368249 | 0.80 | ALDH1A1 (0.38) | ALDH1A1GAAALOX12HTTHIF1A | |
| SCHEMBL20285948 | 0.78 | TRPA1 (0.52) | LMNATRPA1ALDH1A1CHRM1SLC6A2 | |
| SCHEMBL14228579 | 0.78 | LMNA (0.54) | LMNATRPA1PTGS1CACNA1CALDH1A1 | |
| SCHEMBL24497708 | 0.77 | CYP19A1 (0.38) | LMNATRPA1PTGS1CACNA1CALDH1A1 | |
| SCHEMBL18999634 | 0.77 | HTR1D (0.40) | LMNATRPA1PTGS1CACNA1CALDH1A1 | |
| SCHEMBL21725473 | 0.77 | KMT2A (0.47) | LMNATRPA1ALDH1A1GAAHTT | |
| SCHEMBL21756916 | 0.77 | GABRA1 (0.39) | LMNATRPA1ALDH1A1GABRA1GABRB2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250271753-A1 | MICROCAPSULE IMAGING SYSTEM INCLUDING NON-PHOTOPOLYMERIZABLE REACTIVE DILUENT | POLAROID IP B.V. (NL) | 2025-08-28 | — | — | US | disclosed |
| US-12321095-B2 | Microcapsule imaging system including non-photopolymerizable reactive diluent | POLAROID IP B.V. (NL) | 2025-06-03 | — | — | US | disclosed |
| EP-4537160-A1 | MICROCAPSULE IMAGING SYSTEM INCLUDING NON-PHOTOPOLYMERIZABLE REACTIVE DILUENT | Polaroid IP B.V. (NL) | 2025-04-16 | — | — | EP | disclosed |
| WO-2023237992-A1 | MICROCAPSULE IMAGING SYSTEM INCLUDING NON-PHOTOPOLYMERIZABLE REACTIVE DILUENT | POLAROID IP B.V. (NL) | 2023-12-14 | — | — | WO | disclosed |
| US-20230393459-A1 | MICROCAPSULE IMAGING SYSTEM INCLUDING NON-PHOTOPOLYMERIZABLE REACTIVE DILUENT | POLAROID IP B.V. (NL) | 2023-12-07 | — | — | US | disclosed |
| US-20230141913-A2 | PHENOXY(HETERO)ARYL ETHERS OF ANTIPROLIFERACTIVE ACTIVITY | Xeniopro GmbH (DE) | 2023-05-11 | — | — | US | disclosed |
| US-20230141913-A2 | PHENOXY(HETERO)ARYL ETHERS OF ANTIPROLIFERACTIVE ACTIVITY | Xeniopro GmbH (DE) | 2023-05-11 | — | — | US | disclosed |
| US-20220411426-A1 | SUBSTRATE SELECTIVE INHIBITORS OF INSULIN-DEGRADING ENZYME (IDE) AND USES THEREOF | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2022-12-29 | — | — | US | disclosed |
| US-11040976-B2 | Substrate selective inhibitors of insulin-degrading enzyme (IDE) and uses thereof | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2021-06-22 | — | — | US | disclosed |
| US-20190016723-A9 | SUBSTRATE SELECTIVE INHIBITORS OF INSULIN-DEGRADING ENZYME (IDE) AND USES THEREOF | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2019-01-17 | — | — | US | disclosed |
| US-20180194768-A1 | SUBSTRATE SELECTIVE INHIBITORS OF INSULIN DEGRADING ENZYME (IDE) AND USES THEREOF | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2018-07-12 | — | — | US | disclosed |
| US-8778874-B2 | Glycopeptide antibiotic monomer derivatives | NATIONAL UNIVERSITY CORPORATION NAGOYA UNIVERSITY (JP) | 2014-07-15 | — | — | US | disclosed |
| US-20080097078-A1 | Antibacterial activity against vancomycin-resistant bacteria | SHIONOGI & CO., LTD. (JP) | 2008-04-24 | — | — | US | disclosed |
| CN-1097057-C | Borate photoinitiators from polyboranes | CIBA SC HOLDING AG (CH) | 2002-12-25 | — | — | CN | disclosed |
| EP-1203999-A2 | Photoinitiator comprising a borane and an electron donating compound | Ciba SC Holding AG (CH) | 2002-05-08 | — | — | EP | disclosed |
| EP-0775706-A2 | Borates photoinitiators from polyboranes | Ciba SC Holding AG (CH) | 1997-05-28 | — | — | EP | disclosed |
| US-5411995-A | Free radically curable formulations employing dithiolate catalysts | LOCTITE CORPORATION (US) | 1995-05-02 | — | — | US | disclosed |
| US-5230982-A | Heterocyclic disulfides for crosslinking | THE MEAD CORPORATION (US) | 1993-07-27 | — | — | US | disclosed |
| US-5217760-A | Of a dithiolate and an organic halogen compound and/or tertiary amine coinitiator | LOCTITE CORPORATION (US) | 1993-06-08 | — | — | US | disclosed |
| EP-0467649-A2 | Free radically curable formulations employing dithiolate catalysts | LOCTITE CORPORATION (US) | 1992-01-22 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180194768-A1 | SUBSTRATE SELECTIVE INHIBITORS OF INSULIN DEGRADING ENZYME (IDE) AND USES THEREOF | IDE, SI, GPR119 | LMNA 1974/4885TRPA1 4568/4885PTGS1 3824/4885 |
| US-20220411426-A1 | SUBSTRATE SELECTIVE INHIBITORS OF INSULIN-DEGRADING ENZYME (IDE) AND USES THEREOF | IDE, SI, GPR119 | LMNA 2054/4885TRPA1 4491/4885PTGS1 3340/4885 |
| US-20190016723-A9 | SUBSTRATE SELECTIVE INHIBITORS OF INSULIN-DEGRADING ENZYME (IDE) AND USES THEREOF | IDE, SI, GPR119 | LMNA 2131/4885TRPA1 4453/4885PTGS1 3755/4885 |
| US-20230141913-A2 | PHENOXY(HETERO)ARYL ETHERS OF ANTIPROLIFERACTIVE ACTIVITY | AHR, MUSK, TYR | LMNA 2488/4885TRPA1 2803/4885PTGS1 1708/4885 |
| US-11040976-B2 | Substrate selective inhibitors of insulin-degrading enzyme (IDE) and uses thereof | IDE, SI, GPR119 | LMNA 2131/4885TRPA1 4453/4885PTGS1 3755/4885 |
| US-20080097078-A1 | Antibacterial activity against vancomycin-resistant bacteria | CSGALNACT1, MON2, NR2C2 | LMNA 4466/4885TRPA1 4040/4885PTGS1 4716/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.